HONG KONG SAR – Media OutReach – 12 May 2023 – Have you ever imagined earning real-life rewards while participating in a virtual sports experience? Gymetaverse, an international Web 3.0 wellness brand, has partnered with AIR World to introduce the groundbreaking “Play-to-Earn” concept. Using Web 3.0 technology, Gymetaverse can offer a unique fitness experience that rewards users physically and digitally. This partnership marks a significant step forward in the evolution of fitness and wellness, as it incentivizes the general public to engage with the Metaverse while improving their awareness of wellness.
Gymetaverse and AIR World share a common goal of bridging the gap between the physical and virtual worlds, and this partnership takes the shared vision to the next level. AIR World’s innovative approach to introducing a couple of artists from the top Hong Kong boy band to the Metaverse brings a new level of reality and emotional depth to the virtual world. Unlike most virtual artists who are confined to the Metaverse, the stars are real-life sensations that interact with shared experiences and emotions with their fans in reality, creating a “real” experience by bringing “real” senses into the virtual world. This groundbreaking approach paves the way for exciting future opportunities that blur the lines between real life and the Metaverse.
Interactive games and missions like the 3 Fun Slam-Dunk Challenge and the Lacrosse Challenge will be featured, encouraging users to participate in fitness activities and continue their journey towards a healthier lifestyle. These missions will not only be fun and engaging, but they will also educate users on the benefits of physical activities and inspire them to make fitness a part of their daily routine by playing games.
Gymetaverse’s building in AIR World bridges two Metaverses, allowing users to interact with both realms and cross-educate the concept of “play-to-earn.” This introduction of the “play-to-earn” concept sets the foundation for the upcoming GameFi wellness mobile app from Gymetaverse, which is set to launch later this year. The app will take the “play-to-earn” concept to the next level- “fit-to-earn”, offering the general public an innovative approach to incentivizing their fitness and wellness journeys in the Metaverse. This game-changing app promises to revolutionize the fitness industry and bring exciting fitness memories and moments to the Metaverse, offering you and I an one-of-a-kind experience.
Overall, this partnership between Gymetaverse and AIR World represents a new era of immersive fitness experiences in the virtual world with endless possibilities. And this collaboration aims to build an interactive connection between the real and the virtual world, making it an unforgettable and a “real” experience in the Metaverse.
The issuer is solely responsible for the content of this announcement.
Gymetaverse
Gymetaverse is an international Web 3.0 wellness brand that uses Web 3.0 technology to offer everyone a unique fitness experience that rewards users physically and digitally.
Ramping up on their decarbonisation efforts, the steel manufacturer seeks to enhance the competitiveness of Indonesia’s steel industry on the global stage.
JAKARTA, INDONESIA – Media OutReach – 12 May 2023 – PT Gunung Raja Paksi Tbk (GRP),a member of the Gunung Steel Group, is further championing Indonesia’s sustainability agenda by kickstarting a value chain ecosystem for the nation’s steel sector. With an aim to enhance the competitiveness of Indonesia’s steel industry while advancing sustainability goals, a Focus Group Discussion (FGD) was recently held with key members of the Ministry of Industry, Ministry of Trade, the Net Zero Hub of the Indonesia Chamber of Commerce (KADIN), the World Resources Institute, PT Tata Metal Lestari (Tatalogam Group) as well as the University of Indonesia among other partners.
The preliminary FGD initiates an important conversation for the heavy-weight industry and GRP aims to achieve the following:
Explore potential collaborations and partnerships with a shared vision and mission to achieve decarbonisation and greenhouse gas (GHG) emission reductions.
Lead the formation of a green industry-based ecosystem that promotes sustainability and raise awareness to support the government’s targets for achieving Nationally Determined Contribution (NDC) and Net Zero in 2060, with a realistic and measurable roadmap and work plan.
Improve the competitiveness of the national steel industry by adopting sustainability principles and optimising the Indonesian Green Industry Standard, which would be recognised by all international green standards, and encourage competitive export activities.
Emerge as a leading community and centre of excellence for green industry by delivering world-class, environmentally friendly steel products and total solutions with transparent environmental disclosures, to consumers and investors worldwide.
The collaboration and information sharing between industry players is critical to reducing GHG emissions on a global scale as every product is linked to different industry players, and emissions are produced at each stage of the value chain. Steel manufacturing is a prime example of the key value chain as steel is a core building material that is traded between countries. The global steel industry is one of the drivers of pollution globally, contributing up to 4.1% of the world’s total CO2 emissions and about 3.2% of all GHG emissions.[1] With more than 70% of global steel production operating in Asia, the industry must innovate to reduce direct and indirect fuel consumption and CO2 emissions[2]. An ambitious, long-term plan for the industry is crucial to achieving decarbonisation targets and reducing emissions.
“Decarbonisation and sustainability are ambitious goals that no single company can achieve alone. It requires the collaboration of every stakeholder across the value chain. Today’s supply chains are more interconnected than ever. To achieve a more sustainable ecosystem, we need to align our goals and action plans in reducing GHG emissions. The recent FGD is a crucial step in bringing together diverse stakeholders and understanding their perspectives towards sustainability. By working together, we are determined to set Indonesia’s steel industry as a standard for sustainability which can inspire other countries to follow suit. We are determined to lead this effort and look forward to working closely with like-minded industry players to build a cleaner future,” said Kimin Tanoto, Member of the Executive Committee at GRP.
The Indonesian government has also articulated its plans towards sustainability and earlier this year, the country has reaffirmed its commitment to achieving its Enhanced Nationally Determined Contribution (ENDC) to reduce its emissions by approximately 31.9% unconditionally and achieve Net Zero emissions by 2060 or sooner. This is a goal which GRP and its partners are committed to supporting.
“Together with GRP, we have initiated the conversation around establishing a green ecosystem via the forum as a commitment between both steel companies to speed up and enhance the target of achieving net zero by 2060. GRP is our strategic supplier, and through our efforts we have supplied customers in over 16 countries, with sustainably produced steel, while staying compliant to the sustainability standards of each country” said Stephanus Koeswandi, Vice President, PT Tata Metal Lestari.
Following its recent sustainability initiatives, which include developing an ESG Strategy Handbook and reiterating their commitment to reducing GHG emissions via the Net Zero Roadmap, GRP envisions a future where low carbon steel will become a core building material in every infrastructure. As part of its ESG strategy, GRP has been working closely with suppliers in its supply chain to ensure compliance and alignment on ESG criteria and standards. GRP’s Net Zero Roadmap outlines concrete steps towards decarbonisation, including fuel switching, green power sourcing, and carbon offsetting.
[1] World Resources Institute (WRI) Report 2007 “Slicing the Pie: Sector-Based Approaches to International Climate Agreements
The issuer is solely responsible for the content of this announcement.
About GRP
PT Gunung Raja Paksi Tbk (GRP) is part of the Gunung Steel Group, which is one of Indonesia’s major private steel businesses. Our company began its operations in 1970 in Medan, North Sumatra, by producing hot steel, then progressed to manufacture steel beams and sheets.
With over 50 years of steel industry experience, GRP has a production capacity of 2,200,000 tons of high-quality steel annually approved by local and international certifying company.
Today, our company has become one of the largest private steel companies in Indonesia. Gunung Raja Paksi, “Shaping Tomorrow”. Together we develop a better future.
The Lao Youth Union (LYU), the United Nations Population Fund (UNFPA), and the Laos-China Railway (LCR) launched counseling helpline materials at all railway stations and substations in Laos on Friday.
The chair reserved for Myanmar's leader is left unoccupied during the retreat session at the 42nd ASEAN Summit in Labuan Bajo, East Nusa Tenggara province, Indonesia, Thursday, May 11, 2023. (Mast Irham/Pool Photo via AP)
LABUAN BAJO, Indonesia (AP) — Indonesian President Joko Widodo somberly acknowledged to fellow Southeast Asian leaders Thursday that no progress has been made to end the civil strife gripping Myanmar and renewed a call for an end to the violence, including a recent airstrike a rights group called an “apparent war crime.”
HONG KONG SAR – Media OutReach – 12 May 2023 – On 10 May, themed on “Technology Redefined”, the 3rd BEYOND International Science and Technology Innovation Expo – also known as BEYOND Expo 2023 kicked off at the Venetian Macau Convention and Exhibition Center. This year is the third consecutive year that Fosun has participated in the Expo with the latest innovative achievements of Fosun Pharma and ecosystem enterprises in the Health segment, fully showcasing the latest R&D achievements under the strategy of “innovation-driven” and “global operation”.
The Healthcare Summit, one of the three major sub-brands of the Expo, has attracted great attention. Fosun and Fosun Pharma, together with well-known domestic and foreign pharmaceutical companies, discussed pharmaceutical innovation, industry trends and solutions to global health challenges. Li Haifeng, Fosun Global Partner and Chairman of Fosun Foundation, was invited to the Expo as a guest at the Healthcare Summit Forum and in-depth exchanged with visiting guests and partners.
Li Haifeng said, “As an innovation-driven global consumer group rooted in China, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of one billion families in Health, Happiness and Wealth. Ecosystem enterprises in the Health segment, represented by Fosun Pharma, firmly implement the strategy of innovation and internationalization, accelerate innovation and transformation, and have achieved considerable development in the global clinical development and commercialization of innovative drugs.”
In 2022, Fosun Pharma continued to increase R&D investment and achieved many breakthroughs; its revenue amounted to RMB43.952 billion, with a year-on-year growth of 12.66%. In particular, the core pharmaceutical manufacturing segment made outstanding contributions; the revenue of innovative drugs and biosimilar drugs (mainly products launched after 2019) exceeded RMB10 billion in 2022, marking a solid step in innovation and transformation.
Chinese innovation and global development in the field of biopharmaceuticals
In recent years, the R&D and launch of innovative drugs have ushered in a period of rapid development, and the proportion of innovative drugs has continued to increase. China encourages clinical value-oriented innovation and promotes the differentiation and globalization of R&D of local pharmaceutical companies.
In 2005, artesunate, an innovative drug self-developed and manufactured by Fosun Pharma in China, was pre-qualified by the World Health Organization (WHO-PQ), representing a breakthrough for Chinese self-developed innovative drug to go global. As the first Chinese pharmaceutical brand well recognized in Africa, Artesun® (artesunate for injection) has been used to treat over 56 million severe malaria patients worldwide and has provided more prevention and treatment options for children with malaria.
As of December 2022, Fosun Pharma had 30 antimalarial drugs prequalified by the WHO, ranking first in the world. It is also currently one of the world’s largest antimalarial drug developers and manufacturers. Fosun Pharma has become a core supplier of antimalarial drugs to the Global Fund, the United Nations Children’s Fund (UNICEF), WHO, and national drug procurement centers in Africa.
Li Haifeng said, “Fosun will further accelerate the R&D and transformation of innovative technologies and products, while shouldering the social responsibility of a global enterprise, actively expanding cooperation opportunities with global leading enterprises, and jointly contributing to major global medical issues and public health.”
International forward-looking layout in the field of biopharmaceuticals to serve Chinese patients
With regards to serving Chinese patients with cutting-edge technologies in the global pharmaceutical industry, Li Haifeng said that, “Fosun Kite, a key enterprise specializing in cell therapy in Fosun’s Health segment, has introduced the world’s cutting-edge CAR-T technology to China, bringing hope of a cure to advanced lymphoma patients with only 5-6 months of survival. This is also the original intention and mission of Fosun Kite when it started to deploy CAR-T six years ago.”
In early 2017, Fosun Pharma and Kite Pharma of the United States decided to establish a joint venture, Fosun Kite, focusing on the R&D and industrialization of CAR-T cell therapy in the Chinese mainland. Four years later, Fosun Kite successfully launched Yikaida in the Chinese mainland in June 2021, which became the first cell therapy approved for launch in China. Since then, China’s cancer treatment development has entered a new era.
In the past two years, Yikaida has been used to cure more than 400 patients, and nearly 60% of the patients achieved complete remission, with an objective remission rate of more than 80%. “After these patients were treated with Yikaida, they returned to their families and society normally. We are very excited and delighted by the recovery of each patient.” Li Haifeng also expressed the hope to introduce Yikaida to Macau to benefit more patients.
Deeply cultivating Macau and joining hands with the Greater Bay Area to usher in the spring of the health industry
As the Guangdong-Hong Kong-Macau Greater Bay Area (GBA) continues to improve in the national development strategy, Fosun has allocated more resources to support the development of the GBA. Under the guidance of the two national strategies of “Healthy China 2030” and “Digital China”, after years of intensive industrial development, Fosun Health has owned and operated many general hospitals with brand and medical capability advantages in the Greater Bay Area, such as Foshan Fosun Chancheng Hospital, Shenzhen Hengsheng Hospital, Zhuhai Chancheng Hospital, and Guangzhou Xinshi Hospital. While deepening the layout, it has continuously promoted the online and offline integration of medical institutions and enhanced the regional medical and healthcare service model.
In addition, with the support of the Macau SAR government, Comirnaty (BNT162b2) and Comirnaty bivalent mRNA vaccines jointly developed by Fosun Pharma and BioNTech, a German biotechnology company have been approved as regularly imported vaccines in Macau SAR, covering both public and private markets. Fosun Health is also one of the first platforms in the Chinese mainland to provide one-stop vaccination service of the Comirnaty mRNA vaccines. Through the Fosun Health APP or mini program, Fosun Health provides services such as vaccine consultation, vaccine appointment, vaccination, and online consultation.
Li Haifeng said, “Macau is an important part of the development of the GBA. Fosun has always been very optimistic about the development potential of Macau. As an important hub and platform for the exchange and development between the Chinese mainland and Portuguese-speaking countries, Macau plays a pivotal role in economic, cultural, commercial and other sectors. Fosun has already established industrial presence in Portugal and Portuguese-speaking countries. In the future, Fosun will continue to deepen the development of various industries and conduct more businesses in Macau.”
The 3rd BEYOND Expo is open to the public from 10 May to 12 May. Fosun Pharma, together with member enterprises in the pharmaceutical and healthcare services sectors, and Fosun Lead, an in-depth incubation platform, have set up a booth with a number of interactive activities in the Life Sciences Exhibition Area (Booth No. B28) at the Expo. During the Expo, shuttle services have been arranged to pick up and drop off visitors to receive Comirnaty vaccine at the Macau University of Science and Technology Hospital (University Hospital) COVID-19 vaccination center. Hashtag: #Fosun
The issuer is solely responsible for the content of this announcement.